⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLNO News
Soleno Therapeutics, Inc. Common Stock
SLNO Shareholder Alert: May 5, 2026 Lead Plaintiff Deadline in Soleno Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm
globenewswire.com
SLNO
SLNO Shareholder Alert: May 5, 2026 Lead Plaintiff Deadline in Soleno Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm
globenewswire.com
SLNO
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SLNO
Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action filed by Robbins Geller Rudman & Dowd LLP
businesswire.com
SLNO
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
businesswire.com
SLNO
Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
businesswire.com
SLNO
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
prnewswire.com
SLNO
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action
businesswire.com
SLNO
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SLNO
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SLNO